Edward A. Lew, MD

Adjunct Assistant Professor, Medicine

edward.lew@va.gov
View full profile at BUMC

Biography

Dr. Lew, MD is a practicing Gastroenterologist in Jamaica Plain, MA. Dr. Lew graduated from New York University School of Medicine in 1992 and has been in practice for 26 years. He completed a residency at UCLA Medical Center. Dr. Lew also specializes in Internal Medicine.

Other Positions

  • VA Boston Healthcare System

Websites

Education

  • New York University School of Medicine, MD
  • Yale University School of Medicine, MPH
  • Columbia University, BS

Publications

  • Published on 2/27/2024

    Huang Q, Lew E, Cheng Y, Huang K, Deshpande V, Shinagare S, Yuan X, Gold JS, Wiener D, Weber HC. Prognostic factors in clinicopathology of oesophagogastric adenocarcinoma: a single-centre longitudinal study of 347 cases over a 20-year period. Pathology. 2024 Jun; 56(4):484-492. PMID: 38480051.

    Read at: PubMed
  • Published on 2/27/2024

    Huang Q, Lew E, Cheng Y, Shinagare S, Deshpande V, Gold JS, Wiener D, Weber HC. Esophageal adenocarcinoma heterogeneity in clinicopathology and prognosis: A single center longitudinal study of 146 cases over a 20-year period. Ann Diagn Pathol. 2024 Jun; 70:152285. PMID: 38518703.

    Read at: PubMed
  • Published on 5/5/2023

    Huang Q, Cheng Y, Lew E, Shi J, Wiener D, Weber HC. Patients with esophageal adenocarcinoma showed better prognosis than those with adenocarcinoma of the gastroesophageal junction. J Dig Dis. 2023 Feb; 24(2):98-112. PMID: 36970757.

    Read at: PubMed
  • Published on 10/1/2004

    Fang M, Lew E, Klein M, Sebo T, Su Y, Goyal R. DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: image cytometric DNA analysis in formalin-fixed tissues. Am J Gastroenterol. 2004 Oct; 99(10):1887-94. PMID: 15447746.

    Read at: PubMed
  • Published on 3/1/2004

    Lew EA. Clarithromycin, lansoprazole, and metronidazole eradicated Helicobacter pylori infection in chronic renal insufficiency. ACP J Club. 2004 Mar-Apr; 140(2):40. PMID: 15122860.

    Read at: PubMed
  • Published on 4/17/2003

    Lew EA, Stoffel EM. Natalizumab for active Crohn's disease. N Engl J Med. 2003 Apr 17; 348(16):1599; author reply 1599. PMID: 12700383.

    Read at: PubMed
  • Published on 12/1/2001

    Metz DC, Forsmark C, Lew EA, Starr JA, Soffer EF, Bochenek W, Pisegna JR. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Am J Gastroenterol. 2001 Dec; 96(12):3274-80. PMID: 11774936.

    Read at: PubMed
  • Published on 7/1/2001

    Lew EA, Goyal RK. The enigma of short-segment Barrett's esophagus. Indian J Gastroenterol. 2001 Jul-Aug; 20(4):130-1. PMID: 11497168.

    Read at: PubMed
  • Published on 4/1/2000

    Lew EA, Pisegna JR, Starr JA, Soffer EF, Forsmark C, Modlin IM, Walsh JH, Beg M, Bochenek W, Metz DC. Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Gastroenterology. 2000 Apr; 118(4):696-704. PMID: 10734021.

    Read at: PubMed
  • Published on 10/1/1999

    Lew EA. Review article: pharmacokinetic concerns in the selection of anti-ulcer therapy. Aliment Pharmacol Ther. 1999 Oct; 13 Suppl 5:11-6. PMID: 10555604.

    Read at: PubMed

View 11 more publications: View full profile at BUMC

View all profiles